ANIP EBITDA Margin
Ani Pharmaceuticals Inc · EBITDA Margin
ANIP EBITDA Margin
Latest reported26.15%period ending
ANIP TTM EBITDA Margin (-6083.16% → 26.15%)
TTM ebitda margin
High-resolution chart · PNG
ANIP ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 26.1489% | |
| 25.4092% | |
| 25.5497% | |
| 19.7874% | |
| 11.9133% | |
| 9.9192% | |
| 10.274% | |
| 12.6302% | |
| 21.6512% | |
| 24.4778% | |
| 21.898% | |
| 22.7119% | |
| 19.767% | |
| 15.1461% | |
| 7.9144% | |
| -1.78% | |
| -3.4689% | |
| -6.6517% | |
| 1.4417% | |
| 12.6688% | |
| 15.997% | |
| 17.9179% | |
| 13.4923% | |
| 10.964% | |
| 12.5079% | |
| 21.5028% | |
| 29.4209% | |
| 35.0658% | |
| 36.0438% | |
| 35.703% | |
| 34.0075% | |
| 33.0119% | |
| 32.3148% | |
| 31.9609% | |
| 31.8431% | |
| 29.1969% | |
| 29.2951% | |
| 30.8898% | |
| 33.9429% | |
| 41.4653% | |
| 46.2764% | |
| 49.9257% | |
| 51.8854% | |
| 54.5547% | |
| 54.9434% | |
| 47.8785% | |
| 42.6729% | |
| 34.5918% | |
| 20.9755% | |
| 21.4883% | |
| 5.4867% | |
| -15.6426% | |
| -117.753% | |
| -661.4482% | |
| -1,020.2523% | |
| -7,118.8325% | |
| -7,353.7% | |
| -8,944.3494% | |
| -11,707.8378% | |
| -12,012.5674% | |
| -16,364.4073% | |
| -20,513.4045% | |
| -1,755.7079% | |
| -1,579.9365% | |
| -1,410.3898% | |
| -1,201.8674% | |
| -2,926.5681% | |
| -403.1918% | |
| -442.4926% | |
| -477.0691% | |
| -477.9658% | |
| -3,756.7847% | |
| -3,057.8355% | |
| -2,190.7559% | |
| -1,742.1256% | |
| 23.7466% | |
| 32.6244% | |
| 34.7052% | |
| 24.6391% | |
| -1,643.1521% | |
| -2,086.7883% | |
| -3,071.3993% | |
| -3,561.558% | |
| -5,372.7789% | |
| -9,017.4358% | |
| -12,654.2525% | |
| -15,618.5797% | |
| 29,719.8138% | |
| 45,471.3104% | |
| 31,281.6553% | |
| -11,044.5634% | |
| -237.254% | |
| -138.1776% | |
| -133.8613% | |
| -132.8624% | |
| 569.026% | |
| 7,780.5444% | |
| 330,192,600% | |
| 291,070,800% | |
| -134.3343% |